News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ) CEO: We Have No Plans To Leave The U.S.


7/18/2014 8:10:34 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Johnson & Johnson’s strong second-quarter earnings are thanks to the company’s focus on long-term goals, particularly in the pharmaceutical business, said CEO Alex Gorsky.

Gorsky joined FBN’s Maria Bartiromo Thursday to discuss the company’s earnings and future plans. Johnson & Johnson (JNJ) sales grew by 9.1% in the second quarter to $19.5 billion, beating expectations of $18.99 billion.

Help employers find you! Check out all the jobs and post your resume.

Read at Fox News
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES